Browse
Submit Data
Databases
API
Help

Dataset Information

56 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Hexa-kis-(dimethyl-formamide-κO)manganese(II) μ-oxido-bis-[trichlorido-ferrate(III)].

ABSTRACT: The title compound, [Mn(C(3)H(7)NO)(6)][Fe(2)Cl(6)O], was obtained unintentionally as a product of an attempted synthesis of heterometallic complexes with Schiff base ligands using manganese powder and FeCl(3)·6H(2)O as starting materials. In the [Fe(2)OCl(6)](2-) anion, the O atom and the Fe atom occupy positions with site symmetry [Formula: see text] and 3, respectively, resulting in a linear Fe-O-Fe angle and a staggered conformation. The octa-hedrally surrounded cation (site symmetry [Formula: see text]) and the [Fe(2)Cl(6)O](2-) anion are alternately stacked along [001].

SUBMITTER: Chygorin EN

PROVIDER: S-EPMC3246982 | biostudies-literature | 2011 Nov

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Hexa-kis-(dimethyl-formamide-κO)manganese(II) μ-oxido-bis-[trichlorido-ferrate(III)].

Chygorin Eduard N EN Petrusenko Svitlana R SR Kokozay Volodymyr N VN Smal Yuri O YO Omelchenko Irina V IV Shishkin Oleg V OV

Acta crystallographica. Section E, Structure reports online 20111022 Pt 11

The title compound, [Mn(C(3)H(7)NO)(6)][Fe(2)Cl(6)O], was obtained unintentionally as a product of an attempted synthesis of heterometallic complexes with Schiff base ligands using manganese powder and FeCl(3)·6H(2)O as starting materials. In the [Fe(2)OCl(6)](2-) anion, the O atom and the Fe atom occupy positions with site symmetry [Formula: see text] and 3, respectively, resulting in a linear Fe-O-Fe angle and a staggered conformation. The octa-hedrally surrounded cation (site symmetry [Formul ...[more]

PMID: 22219802

Similar Datasets

Hexa-kis-(dimethyl sulfoxide-κO)calcium μ(6)-oxido-dodeca-kis-μ(2)-oxido-hexa-oxido-hexa-tungstate(VI).

Project description:In the title compound, [Ca(C(2)H(6)OS)(6)][W(6)O(19)], the cation and anion both have a crystallographically imposed centre of symmetry. The Ca(II) atom in the cation is coordinated by six O atoms from six dimethyl sulfoxide ligands in a distorted octa-hedral geometry. The [W(6)O(19)](2-) isopolyanion possesses the well-known Lindqvist structure in which each W(VI) atom is coordinated by four μ(2)-O, one terminal O and one μ(6)-O atom.

| S-EPMC3344417 | biostudies-literature

Hexa-kis-(dimethyl-formamide-κO)manganese(II) (dimethyl-formamide-κO)pentakis(-thio-cyanato--κN)chromate(III).

Project description:The title compound, [Mn(C(3)H(7)NO)(6)][Cr(NCS)(5)(C(3)H(7)NO)], was obtained unintentionally as a product of an attempted synthesis of heterometallic complexes based on Reineckes anion using manganese powder, Reineckes salt and 1-(2-hy-droxy-eth-yl)tetra-zole as starting materials. The crystal structure of the complex consists of an [Mn(dmf)(6)](2+) cation and a [Cr(NCS)(5)(dmf)](2-) anion (dmf = dimethyl-formamide). The Mn(II) and Cr(III) atoms show a slightly distorted octa-hedral MnO(6) and CrN(5)O coordination geometries with adjacent angles in the range 85.29 (13)-95.96 (14)°.

| S-EPMC3379144 | biostudies-literature

Octa-kis(dimethyl sulfoxide-κO)cerium(III) μ(6)-oxido-dodeca-μ(2)-oxido-hexa-oxidohexa-molybdate(VI) dimethyl sulfoxide tetrasolvate.

Project description:The title complex, [Ce(C(2)H(6)OS)(8)](2)[Mo(6)O(19)](3)·4C(2)H(6)OS, was obtained as a byproduct of the reaction of [(C(4)H(9))(4)N](2)[Mo(6)O(19)] with Ce(NO(3))(3)·6H(2)O and phthalic acid in dimethyl-sulfoxide solution. The asymmetric unit consists of a complex [Ce(C(2)H(6)OS)(8)](3+) cation, one and a half of the Lindqvist-type [Mo(6)O(19)](2-) polyanions and two dimethyl-sulfoxide solvent mol-ecules; the half polyanion lies on an inversion center. The Ce(3+) ion is coordinated by eight dimethyl-sulfoxide ligands through the O atoms in the form of a distorted square antiprism. The Ce-O bond lengths range from 2.429 (6) to 2.550 (5) Å. The cohesion of the structure is ensured by S⋯O [3.115 (6), 3.242 (10) and 3.12 (3) Å], O⋯O [3.037 (10) Å] and C-H⋯O inter-actions between cations and anions. The S and C atoms of a dmso ligand are disordered over three sites in a 0.45:0.30:0.25 ratio. The dimethyl-sulfoxide solvent mol-ecules are highly disordered and could not be modelled successfully; their contribution was therefore removed from the refinement using the SQUEEZE routine in PLATON [Spek (2009 ▶). Acta Cryst. D65, 148-155]. Potential solvent-accessible voids of 500.0 Å(3) occur in the crystal structure.

| S-EPMC3393199 | biostudies-literature

cyclo-Hexa-μ(2)-diphenyl-acetato-κO:O'-hexa-μ(3)-oxido-hexa-kis[phenyl-tin(IV)].

Project description:In the cyclo-hexa-meric centrosymmetric title compound, [Sn(6)(C(6)H(5))(6)(C(14)H(11)O(2))(6)O(6)], each bridging oxide O atom is connected to three Sn atoms and each carboxyl-ate group bridges a pair of Sn atoms so that the three independent Sn atoms all adopt SnCO(5) distorted octa-hedral geometries, resulting in a drum-shaped Sn(6)O(6) core.

| S-EPMC2960123 | biostudies-literature

Di-μ(3)-chlorido-tetra-μ(2)-chlorido-dichloridobis(dimethyl-formamide-κO)hexa-kis-(1H-imidazole-κN)tetra-cadmium.

Project description:The centrosymmetric mol-ecule of the title complex, [Cd(4)Cl(8)(C(3)H(4)N(2))(6)(C(3)H(7)NO)(2)], contains four Cd(II) atoms, six imidazole, two dimethyl-formamide and eight chloride ligands. The structure shows a novel chloride-bridged tetra-nuclear cadmium quasi-cubane cluster. The coordination geometry of all Cd(II) atoms is distorted octa-hedral, with the two metal atoms in the asymmetric unit in different coordination environments. One of the Cd(2+) ions is coordinated by five Cl(-) ions and by one N atom from an imidazole ligand, while the second is coordinated by three chloride ligands, two N atoms from two imidazole ligands and one O atom from a dimethyl-formamide mol-ecule. Inter-molecular N-H⋯Cl hydrogen bonds link the mol-ecules into a two-dimensional polymeric structure parallel to the ab plane.

| S-EPMC3201276 | biostudies-literature

Crystal structure of di-μ-chloro-acetato-hexa-kis-(di-methyl-formamide)-tetra-kis-(μ-N,2-dioxido-benzene-1-carboximidato)tetra-manganese(III)disodium dimethyl-formamide disolvate.

Project description:The synthesis, crystal structure, and FT-IR data for the title compound, [Na2Mn4(C2H2ClO2)2(C7H4NO3)4(C3H7NO)6]·2C3H7NO or Na2(O2CCH2Cl)2[12-MCMn(III) N(shi)-4](DMF)6·2DMF, where MC is metallacrown, shi(3-) is salicyl-hydroximate, and DMF is N,N-di-methyl-formamide, is reported. The macrocyclic metallacrown consists of an -[Mn(III)-N-O]4- ring repeat unit and the metallacrown captures two Na(+) ions in the central cavity above and below the plane of the metallacrown. Each Na(+) ion is seven-coordinate and is bridged to two ring Mn(III) ions, through either a coordinating DMF mol-ecule or a chloro-acetate anion. The ring Mn(III) ions have either a tetra-gonally distorted octa-hedral geometry or a distorted square-pyramidal geometry. Weak C-H⋯O inter-actions, in addition to pure van der Waals forces, contribute to the overall packing of the mol-ecules. The complete molecule has inversion symmetry and is disordered over two sets of sites with an occupancy ratio of 0.8783 (7):0.1217 (7). The solvent molecule is also disordered over two sets of sites, with an occupancy ratio of 0.615 (5):0.385 (5).

| S-EPMC4257439 | biostudies-literature

Crystal structure of hexa-kis-(di-methyl-formamide-κO)manganese(II) deca-kis-(di-methyl-formamide)-1κ(5) O,2κ(5) O-[μ-octa-deca-tungstodiphosphato(V)-κO:κO']dimanganate(II) di-methyl-formamide disolvate.

Project description:The crystal structure of the title compound, [Mn(C3H7NO)6][{Mn(C3H7NO)5}2(μ-P2W18O62)]·2C3H7NO, reveals that the Wells-Dawson-type polyanion [P2W18O62](6-), through terminal O atoms from the belts, bridges two Mn(II) octa-hedral complexes. In the complex anion [{Mn(dmf)5}2(μ-P2W18O62)](2-), located around a twofold rotation axis, the Mn(II) ions are coordinated by five O atoms from di-methyl-formamide (dmf) ligands and to a terminal O atom from the [P2W18O62](6-) polyanion. Another Mn(II) ion, located on an inversion centre, is coordinated by six O atoms from the dmf ligands and forms the [Mn(dmf)6](2+) cation. The crystal components are connected through numerous weak C-H⋯O hydrogen bonds to construct a three-dimensional network.

| S-EPMC4908550 | biostudies-literature

Crystal structure of hexa-kis-(dimethyl sulfoxide-κO)manganese(II) diiodide.

Project description:The asymmetric unit of the title salt, [Mn(C2H6OS)6]I2, consists of one Mn(II) ion, six O-bound dimethyl sulfoxide (DMSO) ligands and two I(-) counter-anions. The isolated complex cations have an octa-hedral configuration and are grouped in hexa-gonally arranged rows extending parallel to [100]. The two I(-) anions are located between the rows and are linked to the cations through two weak C-H⋯I inter-actions.

| S-EPMC4992903 | biostudies-literature

Tetra-kis(μ-4-azido-benzoato-κO:O')bis-[(N,N-dimethyl-formamide-κO)copper(II)].

Project description:The binuclear title compound, [Cu(2)(C(7)H(4)N(3)O(2))(4)(C(3)H(7)NO)(2)], is a discrete metal-organic compound having a paddle-wheel-type structure. The Cu⋯Cu distance is 2.6366 (5) Å and an inversion center is located at the mid-point of this bond. The Cu(II) cation is coordinated by four carboxyl-ate O atoms from four 4-azido-benzoate ligands, and one O atom from a dimethyl-formamide mol-ecule, forming an overall distorted octahedral geometry when the Cu⋯Cu bond is also considered.

| S-EPMC3254312 | biostudies-literature

Tetra-kis(μ-naphthalene-1-acetato-κO:O')bis-[(N,N-dimethyl-formamide-κO)copper(II)].

Project description:The asymmetric unit of the title compound, [Cu(2)(C(12)H(9)O(2))(4)(C(3)H(7)NO)(2)], contains two independent centrosymmetric dinuclear copper(II) complexes. The central paddle-wheel units are formed by four bridging bidentate naphthalene-1-acetate ligands with two dimethyl-formamide ligands in the axial positions. The unique Cu(II) ions have slightly distorted square-pyramidal coordination geometries. One of the naphthalene rings is disordered over two sets of sites, with refined occpancies of 0.535 (4) and 0.465 (4).

| S-EPMC3297287 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data